| Name | Title | Contact Details |
|---|
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
Johnson Mathers Health Care Inc is a Carlisle, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lane Individual Practice Association is a Eugene, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
St Ann's Home is a Methuen, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.